MobiHealth News January 24, 2022
Participants in HealthTech Build’s recent panel discuss the barriers to adoption for digital therapeutics.
The digital therapeutics industry, encompassing prescription software that aim to treat specific conditions, is continuing to expand. Investors and healthcare stakeholders are beginning to take notice. In December, Pear Therapeutics became one of the first digital therapeutics companies to go public.
However, there are still many questions around the usability and scalability of these products. Unlike traditional prescription drugs, users need to onboard digitally and often need personal technology products to do so. Digital therapeutics often have multiple end users, which means designing for different populations.
“I was lucky enough to be part of some early pilot studies with digital therapeutics products and was able...
Today's Sponsors
Today's Sponsor